Skip to main content

AM Biotechnologies X-Aptamer Selection Kit

AM Biotechnologies has launched the X-Aptamer Selection Kit for the in-lab discovery of X-Aptamers, next-generation aptamers that feature amino acid and small-molecule functionality attached to DNA bases and selectively bind to antigens with high affinity. The kit features a combinatorial bead-based library employing a single-round process for the discovery of X-Aptamers. The process takes less than a week, including sample preparation, requires no special lab equipment or procedures, and enables the discovery of X-Aptamers for up to five targets in parallel per kit. The introductory price for the kit is $500.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.